niacinamide has been researched along with Fibrosarcoma in 8 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Fibrosarcoma: A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Sorafenib is a multi-kinase inhibitor that targets rapidly accelerated fibrosarcoma (RAF), vascular endothelial growth factor receptor (VEGFR)-1, VEGFR-2, VEGFR-3, platelet-derived growth factor receptor-β (PDGFR-β), and KIT." | 4.12 | Sorafenib inhibits tumor cell growth and angiogenesis in canine transitional cell carcinoma. ( Maeda, S; Momoi, Y; Yokota, S; Yonezawa, T, 2022) |
| "We hypothesized that the combination of pentoxifylline (PTX) and nicotinamide (NA) can reduce the radioresistance of FSaII murine fibrosarcoma by improving oxygenation of the hypoxic tumour cells." | 3.68 | Improved tumour oxygenation and radiosensitization by combination with nicotinamide and pentoxifylline. ( Lee, I; Levitt, SH; Song, CW, 1993) |
| " Fluorine-19 NMR spectroscopic measurements from solid Radiation-Induced Fibrosarcoma (RIF-1) tumors in C3H mice showed a statistically significant improvement in tumor pO2 for a Nicotinamide-treated group, with a delta pO2 = 4." | 3.68 | Assessment of changes in murine tumor oxygenation in response to nicotinamide using 19F NMR relaxometry of a perfluorocarbon emulsion. ( Hees, PS; Sotak, CH, 1993) |
| " The purpose of this study was to examine the effects of PENTO alone or in combination with NA (PENTO + NA) on the oxygenation and radio-response of FSaII murine fibrosarcomas of mice." | 1.28 | Increases in tumor response by pentoxifylline alone or in combination with nicotinamide. ( Kim, JH; Lee, I; Levitt, SH; Song, CW, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Yokota, S | 1 |
| Yonezawa, T | 1 |
| Momoi, Y | 1 |
| Maeda, S | 1 |
| Karroum, O | 1 |
| Kengen, J | 1 |
| Danhier, P | 1 |
| Magat, J | 1 |
| Mignion, L | 1 |
| Bouzin, C | 1 |
| Verrax, J | 1 |
| Charette, N | 1 |
| Starkel, P | 1 |
| Calderon, PB | 1 |
| Sonveaux, P | 1 |
| Feron, O | 1 |
| Grégoire, V | 1 |
| Gallez, B | 2 |
| Jordan, BF | 2 |
| Baudelet, C | 1 |
| Ansiaux, R | 1 |
| Havaux, X | 1 |
| Macq, B | 1 |
| Price, MJ | 1 |
| Li, LT | 1 |
| Tward, JD | 1 |
| Bublik, I | 1 |
| McBride, WH | 1 |
| Lavey, RS | 1 |
| Lee, I | 2 |
| Levitt, SH | 2 |
| Song, CW | 2 |
| Hees, PS | 1 |
| Sotak, CH | 1 |
| Fenton, BM | 1 |
| Lord, EM | 1 |
| Paoni, SF | 1 |
| Kim, JH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Tumor Oximetry Using Electron Paramagnetic Resonance (EPR) With India Ink (Using Carbon Particulates From Carlo Erba [CE])[NCT03321903] | 3 participants (Actual) | Observational | 2017-08-30 | Terminated (stopped due to The research team is exploring device optimization) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 other studies available for niacinamide and Fibrosarcoma
| Article | Year |
|---|---|
Sorafenib inhibits tumor cell growth and angiogenesis in canine transitional cell carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Line, Tumor; Dog Diseases; Dogs; | 2022 |
Tumor reoxygenation following administration of Mitogen-Activated Protein Kinase inhibitors: a rationale for combination with radiation therapy.
Topics: Angiogenesis Inducing Agents; Animals; Apoptosis; Benzamides; Blotting, Western; Diphenylamine; Elec | 2012 |
Physiological noise in murine solid tumours using T2*-weighted gradient-echo imaging: a marker of tumour acute hypoxia?
Topics: Animals; Biomarkers, Tumor; Carbon Dioxide; Cell Hypoxia; Cell Line, Tumor; Computer Simulation; Fib | 2004 |
Effect of nicotinamide and pentoxifylline on normal tissue and FSA tumor oxygenation.
Topics: Analysis of Variance; Animals; Drug Interactions; Fibrosarcoma; Male; Mice; Mice, Inbred C3H; Muscle | 1995 |
Improved tumour oxygenation and radiosensitization by combination with nicotinamide and pentoxifylline.
Topics: Animals; Drug Combinations; Fibrosarcoma; Laser-Doppler Flowmetry; Mice; Microelectrodes; Niacinamid | 1993 |
Assessment of changes in murine tumor oxygenation in response to nicotinamide using 19F NMR relaxometry of a perfluorocarbon emulsion.
Topics: Animals; Body Temperature; Calibration; Emulsions; Fibrosarcoma; Fluorine; Fluorocarbons; Magnetic R | 1993 |
Enhancement of tumor perfusion and oxygenation by carbogen and nicotinamide during single- and multifraction irradiation.
Topics: Animals; Carbocyanines; Carbon Dioxide; Cell Hypoxia; Combined Modality Therapy; Dose Fractionation, | 2000 |
Increases in tumor response by pentoxifylline alone or in combination with nicotinamide.
Topics: Animals; Cell Hypoxia; Combined Modality Therapy; Dose-Response Relationship, Radiation; Drug Therap | 1992 |